A NETWORK META-ANALYSIS (NMA) TO ASSESS THE LONGER-TERM RELATIVE EFFICACY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON METFORMIN

被引：1
|
作者：
Taieb, V [1 ]
Pacou, M. [2 ]
Schroeder, M. [3 ]
Nielsen, A. T. [4 ]
Schubert, A. [5 ]
Neslusan, C. [6 ]
机构：
[1] Amaris, London, England
[2] Amaris, Paris, France
[3] Janssen UK, High Wycombe, Bucks, England
[4] Janssen Cilag AS, Birkerod, Denmark
[5] Janssen Cilag Poland, Warsaw, Poland
[6] Janssen Global Serv LLC, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB6
引用
收藏
页码：A598 / A598
页数：1
相关论文
共 50 条
  • [1] BAYESIAN NETWORK META-ANALYSIS TO ASSESS RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED WITH METFORMIN
    Pacou, M.
    Taieb, V
    Abrams, K. R.
    Diels, J.
    van Sanden, S.
    Garg, M.
    Schroeder, M.
    Kaur, V
    Nielsen, A. T. N.
    Nuhoho, S.
    Neslusan, C.
    Hemels, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A609 - A609
  • [2] BAYESIAN NETWORK META-ANALYSIS TO ASSESS THE RELATIVE EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED ON METFORMIN AND SULPHONYLUREA (MET plus SU)
    Pacou, M.
    Taieb, V
    Abrams, K. R.
    Diels, J.
    van Sanden, S.
    Garg, M.
    Schroeder, M.
    Kaur, V
    Nielsen, A. T. N.
    Nuhoho, S.
    Neslusan, C.
    Hemels, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A431 - A431
  • [3] NETWORK META-ANALYSIS (NMA) TO ASSESS RELATIVE EFFICACY MEASURED AS PERCENTAGE OF PATIENTS TREATED TO HBA1C TARGET WITH CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) INADEQUATELY CONTROLLED ON METFORMIN AND SULPHONYLUREA (MET plus SU)
    Taieb, V
    Pacou, M.
    Schroeder, M.
    Schubert, A.
    Nielsen, A. T.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A598 - A598
  • [4] BAYESIAN NETWORK META-ANALYSIS (NMA) TO ASSESS THE RELATIVE EFFICACY OF CANAGLIFLOZIN MONOTHERAPY OVER 26 WEEKS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Schroeder, M.
    Taieb, V
    Belhadi, D.
    Seyla-Hammer, C.
    Hemels, M.
    Nielsen, A. T.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A56 - A56
  • [5] Longer-term safety and tolerability of canagliflozin in patients with type 2 diabetes: a pooled analysis
    Qiu, Rong
    Balis, Dainius
    Xie, John
    Davies, Michael J.
    Desai, Mehul
    Meininger, Gary
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 553 - 562
  • [6] LONGER-TERM SAFETY AND TOLERABILITY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES: A POOLED ANALYSIS
    Balis, Dainius
    Davies, Michael J.
    Desai, Mehul
    Meininger, Gary
    Qiu, Rong
    Xie, John
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S293 - S294
  • [7] Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin
    Rodbard, H. W.
    Seufert, J.
    Aggarwal, N.
    Cao, A.
    Fung, A.
    Pfeifer, M.
    Alba, M.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 812 - 819
  • [8] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
    Wilding, J. P. H.
    Charpentier, G.
    Hollander, P.
    Gonzalez-Galvez, G.
    Mathieu, C.
    Vercruysse, F.
    Usiskin, K.
    Law, G.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1267 - 1282
  • [9] A network meta-analysis to assess options for treatment intensification for patients with type 2 diabetes inadequately controlled on dual therapy
    Schroeder, M.
    Taieb, V.
    Pacou, M.
    Ho, S.
    Nielsen, A. T.
    Schubert, A.
    Neslusan, C.
    [J]. DIABETOLOGIA, 2015, 58 : S347 - S347
  • [10] Efficacy and safety of canagliflozin in patients with type 2 diabetes A meta-analysis of randomized controlled trials
    Xiong, Wei
    Xiao, Ming Yue
    Zhang, Mei
    Chang, Fei
    [J]. MEDICINE, 2016, 95 (48) : e5473
12345